🔥🐔 BizChicken 🐔🔥

Companies Similar to Personalis, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc. logo
Market Cap: Low
Employees: Low

Probody technology platform

Cytom X Therapeutics, Inc. is an oncology-focused biopharmaceutical company that develops antibody therapeutics based on its Probody technology platform for treating cancer. Its product candidates include CX-2009, CX-2029, BMS-986249, BMS-986288, CX-2043, and CX-904, targeting various cancers and currently in clinical trials.

Tags: antibody therapeutics, biopharmaceuticals, cancer treatment, clinical trials, oncology

Symbol: CTMX

Recent Price: $1.02

Industry: Biotechnology

CEO: Dr. Sean A. McCarthy DPHIL

Sector: Healthcare

Employees: 120

Address: 151 Oyster Point Boulevard, South San Francisco, CA 94080

Phone: 650 515 3185

Last updated: 2024-12-31

Pyxis Oncology, Inc.

Pyxis Oncology, Inc. logo
Market Cap: Low
Employees: Lowest

PYX-106, PYX-102, PYX-201, PYX-202, PYX-203

Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, focuses on developing therapies to treat various cancers through immune-oncology and antibody drug conjugate product candidates.

Tags: antibody drug conjugate, biopharmaceutical, cancer therapy, immune-oncology, solid tumors

Symbol: PYXS

Recent Price: $1.56

Industry: Biotechnology

CEO: Dr. Lara S. Sullivan M.D., MBA

Sector: Healthcare

Employees: 55

Address: 35 Cambridgepark Drive, Cambridge, MA 02140

Phone: 617 221 9059

Last updated: 2024-12-31

GeneDx Holdings Corp.

GeneDx Holdings Corp. logo
Market Cap: High
Employees: Medium

Centrellis health intelligence platform

Gene Dx Holdings Corp. is a patient-centered health intelligence company focused on transforming healthcare by leveraging AI and machine learning on clinical and genomic data to improve individual health outcomes.

Tags: AI, genomics, health intelligence, healthcare, machine learning

Symbol: WGS

Recent Price: $76.58

Industry: Medical - Healthcare Information Services

CEO: Ms. Katherine A. Stueland

Sector: Healthcare

Employees: 1000

Address: North Tower, Stamford, CT 06902

Phone: 800 298 6470

Last updated: 2024-12-31

Celularity Inc.

Celularity Inc. logo
Market Cap: Lowest
Employees: Low

CYCART-19, CYNK-001, CYNK-101, APPL-001, PDA-002

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and Bio Banking.

Tags: biotechnology, cancer, cell therapies, immune diseases, infectious diseases, placental-derived

Symbol: CELU

Recent Price: $2.05

Industry: Biotechnology

CEO: Dr. Robert Joseph Hariri M.D., Ph.D.

Sector: Healthcare

Employees: 120

Address: 170 Park Avenue, Florham Park, NJ 07932

Phone: 908 768 2170

Leadership

  • Robert J. Hariri, M.D., Ph.D., Chairperson, Founder, and CEO
  • David Beers, CFA, Chief Financial Officer
  • Stephen Brigido, DPM, President, Degenerative Diseases
  • John Haines, Global Manager and Chief Administrative Officer
  • K. Harold Fletcher, Esq., General Counsel & Chief Compliance Officer
  • John Colerangle, DVM, Ph.D., Regulatory Affairs
  • Anna Gosiewska, Ph.D., R&D, Degenerative Diseases
  • Sharmila Koppisetti, M.D., Clinical Development Immunology & Drug Safety
  • Carmine Palummo, Corporate Operations
  • Tim Wilk, Technical Operations
  • Robert J. Hariri, M.D., Ph.D, Chairperson, Founder & CEO
  • Peter Diamandis, M.D., Director
  • Dean Kehler, Director
  • Geoffrey Shiu Fei Ling, M.D., Ph.D., Director
  • Diane Parks, Director

Last updated: 2024-12-31

Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc. logo
Market Cap: Low
Employees: Lowest

CLR 131

Cellectar Biosciences, Inc. is a clinical biopharmaceutical company concentrating on the development and commercialization of drugs for cancer treatment.

Tags: biopharmaceutical, cancer treatment, drug development, phospholipid drug conjugate

Symbol: CLRB

Recent Price: $0.29

Industry: Biotechnology

CEO: Mr. James V. Caruso

Sector: Healthcare

Employees: 20

Address: 100 Campus Drive, Florham Park, NJ 07932

Phone: 608 441 8120

Leadership

  • James Caruso, President, CEO and Director
  • Chad Kolean, Chief Financial Officer
  • Shane Lea, Chief Commercial Officer
  • Jarrod Longcor, Chief Operating Officer
  • Andrei Shustov, Senior Vice President, Medical
  • Douglas J. Swirsky, Chairman of the Board
  • Asher Alban Chanan-Khan, MD., Director
  • Frederick W. Driscoll, Director
  • Stefan D. Loren, Ph.D., Director
  • John Neis, Director
  • Cellectar Biosciences, Inc., Company Information

Last updated: 2024-12-31

Champions Oncology, Inc.

Champions Oncology, Inc. logo
Market Cap: Lowest
Employees: Low

Tumorgraft Technology Platform

Champions Oncology, Inc. specializes in personalized cancer care technology solutions, including the Tumorgraft Technology Platform and Lumin Bioinformatics, aimed at enhancing oncology drug development and usage.

Tags: Bioinformatics, Biotechnology, Cancer Care, Oncology, Personalized Medicine, Pharmaceuticals, Translational Oncology

Symbol: CSBR

Recent Price: $8.62

Industry: Biotechnology

CEO: Dr. Ronnie Morris M.D.

Sector: Healthcare

Employees: 210

Address: One University Plaza, Hackensack, NJ 07601

Phone: 201 808 8400

Last updated: 2024-12-31

Precision BioSciences, Inc.

Precision BioSciences, Inc. logo
Market Cap: Lowest
Employees: Low

ARCUS

Precision Bio Sciences, Inc. is a clinical stage gene editing company specializing in in vivo gene editing and ex vivo allogeneic CAR T therapies, including the ARCUS genome editing platform and various investigational CAR T immunotherapies.

Tags: CAR T therapies, allogeneic CAR T, clinical stage, gene editing, genetic disorders, immunotherapy

Symbol: DTIL

Recent Price: $4.26

Industry: Biotechnology

CEO: Mr. Michael Amoroso

Sector: Healthcare

Employees: 109

Address: 302 East Pettigrew Street, Durham, NC 27701

Phone: 919 314 5512

Last updated: 2024-12-31

Illumina, Inc.

Illumina, Inc. logo
Market Cap: Highest
Employees: Highest

Sequencing and Array-based Solutions

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. It serves various markets, enabling genomic solutions in research and clinical settings for life sciences, oncology, and more.

Tags: agriculture, genetic analysis, genomic solutions, life sciences, oncology, reproductive health, sequencing

Symbol: ILMN

Recent Price: $133.57

Industry: Medical - Diagnostics & Research

CEO: Mr. Jacob Thaysen Ph.D.

Sector: Healthcare

Employees: 10590

Address: 5200 Illumina Way, San Diego, CA 92122

Phone: 858 202 4500

Leadership

  • Jacob Thaysen, PhD, Chief Executive Officer
  • Steve Barnard, PhD, Chief Technology Officer
  • Nicole Berry, Head of Region—Americas
  • Todd Christian, Head of Services, Arrays, and Genomics Access
  • Everett Cunningham, Chief Commercial Officer
  • Scott Davies, Interim General Counsel
  • Ankur Dhingra, Chief Financial Officer
  • Pat Leckman, Chief People Officer
  • Kevin Pegels, Chief of Global Operations
  • Carissa Rollins, Chief Information Officer
  • Salli Schwartz, Vice President of Investor Relations
  • Bas Verhoef, Head of Region—Europe
  • Jakob Wedel, Chief Strategy and Corporate Development Officer
  • Gretchen Weightman, Head of Region—Asia Pacific, Middle East, and Africa
  • Jenny Zheng, Head of Region—Greater China
  • Stephen P. MacMillan, Chair of the Board
  • Frances Arnold, PhD, Director
  • Caroline Dorsa, Director
  • Robert S. Epstein, MD, Director
  • Scott Gottlieb, MD, Director
  • Gary S. Guthart, PhD, Director
  • Anna Richo, Director
  • Philip Schiller, Director
  • Sue Siegel, Director
  • Scott B. Ullem, Director
  • Giovanna Prout, Associate Director, Product Marketing
  • Jay Harger, Director, Clinical Genomics

Last updated: 2024-12-31

Myriad Genetics, Inc.

Myriad Genetics, Inc. logo
Market Cap: High
Employees: High

My Risk Hereditary Cancer Test

Myriad Genetics, Inc. is a genetic testing and precision medicine company that develops and commercializes genetic tests for oncology, women's health, and mental health applications.

Tags: DNA sequencing, genetic testing, mental health, oncology, precision medicine, women's health

Symbol: MYGN

Recent Price: $13.63

Industry: Medical - Diagnostics & Research

CEO: Mr. Paul J. Diaz

Sector: Healthcare

Employees: 2700

Address: 320 Wakara Way, Salt Lake City, UT 84108

Phone: 801 584 3600

Last updated: 2024-12-31

Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc. logo
Market Cap: Medium
Employees: Low

Nautilus Platform

Nautilus Biotechnology, Inc. is a development stage life sciences company that engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It was founded in 2016 and is headquartered in Seattle, Washington.

Tags: biotechnology, life sciences, platform technology, proteomics, scientific discovery

Symbol: NAUT

Recent Price: $1.67

Industry: Biotechnology

CEO: Mr. Sujal M. Patel

Sector: Healthcare

Employees: 161

Address: 2701 Eastlake Avenue East, Seattle, WA 98102

Phone: 206 333 2001

Last updated: 2024-12-31

NeoGenomics, Inc.

NeoGenomics, Inc. logo
Market Cap: High
Employees: High

Cancer-focused testing services

Neo Genomics, Inc. operates a network of cancer-focused testing laboratories offering various services such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry, digital imaging, and molecular testing.

Tags: cancer testing, cytogenetics, flow cytometry, laboratories, molecular testing, oncology

Symbol: NEO

Recent Price: $16.92

Industry: Medical - Diagnostics & Research

CEO: Mr. Christopher Michael Smith BSc

Sector: Healthcare

Employees: 2100

Address: 9490 NeoGenomics Way, Fort Myers, FL 33912

Phone: 239 768 0600

Leadership

  • Chris Smith, Chief Executive Officer
  • Jeff Sherman, Chief Financial Officer
  • Warren Stone, Chief Commercial Officer
  • Melody Harris, Chief Operations Officer & President, Informatics
  • Ali Olivo, Executive Vice President, General Counsel & Business Development
  • Hutan Hashemi, JD, Chief Compliance Officer
  • Nathan Montgomery, MD, PhD, Vice President, Medical Services
  • Gary Passman, Chief Culture Officer
  • Kareem Saad, Head of Strategy and Transformation
  • Lynn A. Tetrault, Chair of the Board
  • Bruce K. Crowther, Board Member
  • Elizabeth Floegel, Board Member
  • Neil Gunn, Board Member
  • Alison L. Hannah, MD, Board Member
  • Stephen Kanovsky, Board Member
  • Michael A. Kelly, Board Member
  • David Perez, Board Member
  • Tony Zook, Board Member
  • Derek Lyle, MD, Chief Medical Officer
  • Vladislav Chizhevsky, MD SSBBP, Medical Director, Aliso Viejo, California
  • J. Christopher Mixon, MD, Medical Director, Nashville, Tennessee
  • Anahit Nowrouzi, MD, Medical Director, Fort Myers, Florida
  • Tricia Peters, MD, Medical Director, Houston, Texas Molecular Pathologist, Pharma Services
  • Yin Xu, MD PhD FCAP, Medical Director, Carlsbad and Atlanta; Global Medical Director, Pharma Services
  • Renuka Agrawal, MD, Senior Hematopathologist
  • Todd S. Barry, MD PhD, Senior Hematopathologist
  • Bora Baysal, MD, PhD, Senior Hematopathologist
  • Saskia Boisot, MD, Senior Hematopathologist
  • Wayne W. Chen, MD PhD, Director of Hematopathology Services
  • Rachel Flamholz, MD, Senior Hematopathologist
  • Michael Hayes, MD, Senior Hematopathologist / Surgical Pathologist
  • Anselm Hii, MD, Director of Hematopathology Services
  • Thanh Ho, MD, Senior Hematopathologist
  • Kim Janatpour, MD MA, Senior Hematopathologist
  • Shiping Jiang, MD PhD, Senior Hematopathologist and Surgical Pathologist
  • Sameer S. Khatri, MD, Hematopathologist
  • Madeleine Kraus, MD, Senior Hematopathologist
  • Brian Kwok, MD FCAP, Corporate Director of Hematopathology
  • Keming Lin, MD MS FCAP, Senior Hematopathologist
  • Robert Lin, MD, Senior Hematopathologist
  • Russell L. Maiese, M.D., Senior Hematopathologist
  • Mojdeh Naghashpour, MD PhD, Senior Hematopathologist
  • Viera Nelson, MD, Senior Hematopathologist
  • Dennis P. O’Malley, MD, Senior Hematopathologist
  • Anthony Padula, MD, Senior Hematopathologist
  • Munir Shahjahan, MD MPH, Senior Hematopathologist
  • Jesalyn J. Taylor, MD, Senior Hematopathologist
  • Jian-Feng Wang, MD PhD, Senior Hematopathologist
  • Zhao Wu, MD PhD FCAP, Senior Hematopathologist
  • Aine Yung, MD FCAP, Senior Hematopathologist
  • Sadiq Zaman, MD, Senior Hematopathologist
  • Guohua Zhao, MD PhD, Senior Hematopathologist
  • Mitual Amin, MD, Senior Surgical Pathologist
  • Jerry Chu, MD PhD, Senior Surgical Pathologist
  • Ted Farzaneh, MD, Senior Surgical Pathologist
  • Thomas K. Lee, MD PhD, Director of Surgical Pathology Services
  • Takako Mitsuhashi, MD PhD, Senior Dermatopathologist and Surgical Pathologist
  • Robert Schwartz, MD, Senior Surgical Pathologist
  • Yae K (Kay) Suh, MD, Senior Surgical Pathologist
  • Matthew Geller, DO, Molecular Pathologist
  • Hao Ho, MD, Molecular Pathologist
  • Jennifer Hummel, MD, Senior Molecular Pathologist
  • Armen Kaysan, MD, Molecular Pathologist
  • Kalpana S. Reddy, MD, Hematopathologist and Molecular Pathologist
  • Saed Sadeghi, MD, Molecular Pathologist
  • Ying Wang, MD PhD, Molecular Pathologist
  • Shehla Arain, MD, Senior Surgical Pathologist, Pharma Services
  • Chunghun George Chang, md, Surgical and Hemepath Pathologist, Pharma Services
  • Indu Gupta, MD, Surgical Pathologist, Pharma Services
  • Valerie Harris-Morris, MD, Hemepath Pathologist, Pharma Services
  • Albert Ho, Director of Pharma Pathology Services
  • Henry Tsai, MD PhD, Surgical Pathologist, Pharma Services
  • Sujata Chakraborty, PhD FACMGG, Director, Cytogenetics and Molecular Genetics
  • Li Cheng, PhD FACMG, Associate Director of Cytogenetics
  • Liang Dong, MD PhD, Director of Cytogenetic Services
  • Mohamed M. Elnaggar, MD MS FACMG, Director of Cytogenetic Services
  • Michele Hibbard/Kempik, PhD FACMG, Director of Genetics
  • Fernando J. López-Díaz, PhD, Director of Clinical Science, Research and Development
  • John R. McGill, PhD FACMGG, Medical Director of Cytogenetics and Technical Director of FISH
  • Mike Nahorski, PhD, Director, Clinical and Scientific Alliances
  • Farzad Nooraie, MD, Director of Cytogenetic Services
  • Róisín Puentes, PharmD, PhD, Medical Science Liaison, Medical Affairs
  • Siby Sebastian, Ph.D, FACMGG, DABCC, Lab Director, Research Triangle Park (RTP), North Carolina
  • Guoxian Sun, MD DABMG FACMG, Director of Cytogenetic Services
  • Jadwiga Szymanska, PhD FACMG, Director of Cytogenetics
  • Maya Thangavelu, PhD, Medical Director of Cytogenetics and Technical Director of FISH
  • Qinqin Zha, PhD, Principal Scientist, Associate Director, Scientific Affairs
  • John N. Allan, MD, Scientific Advisory Board Member
  • Rafael Bejar, MD, PhD, Scientific Advisory Board Member
  • James R. Berenson, MD, Scientific Advisory Board Member
  • Riccardo Dalla-Favera, PhD, Scientific Advisory Board Member
  • James Downing, MD, Scientific Advisory Board Member
  • Bernard A Fox, PhD, Scientific Advisory Board Member
  • Gregory Hess, MD, Scientific Advisory Board Member
  • Hatim Husain, MD, Scientific Advisory Board Member
  • Tibor Kovacsovics, MD, Scientific Advisory Board Member
  • Razelle Kurzrock, MD, Scientific Advisory Board Member
  • Gail J. Roboz, MD, Scientific Advisory Board Member
  • Steven T. Rosen, MD, FACP, FASCO, FAIMBE, Scientific Advisory Board Member
  • Mark A. Rubin, MD, Scientific Advisory Board Member

Last updated: 2024-12-31

NexImmune, Inc.

NexImmune, Inc. logo
Market Cap: Lowest
Employees: Lowest

Artificial Immune Modulation

Nex Immune, Inc., a clinical-stage biotechnology company, develops therapies for cancer and immune-mediated diseases using its Artificial Immune Modulation platform. The company is advancing cell therapy candidates including NEXI-001, NEXI-002, and NEXI-003.

Tags: T cell immunotherapies, biotechnology, cancer, cell therapy, immune-mediated diseases, nanoparticle technology

Symbol: NEXI

Recent Price: $0.15

Industry: Biotechnology

CEO: Mr. John Trainer M.B.A.

Sector: Healthcare

Employees: 6

Address: 9119 Gaither Road, Gaithersburg, MD 20877

Phone: 301 825 9810

Leadership

  • Kristi Jones, Chief Executive Officer
  • Mathias Oelke, Ph.D., Chief Scientific Officer
  • Daniel Bednarik Ph.D., Senior Vice President, Molecular Engineering & Protein Design
  • Jack Ragheb, Senior Vice President, Translational Science
  • Tonya Catterton, Vice President, Quality & Compliance
  • Tim Stover, Vice President, Corporate Controller
  • Karen Haslbeck, Head, Human Resources
  • Matt Schiller, Head, Business Development

Last updated: 2024-12-31

Nkarta, Inc.

Nkarta, Inc. logo
Market Cap: Low
Employees: Low

NKX101 and NKX019

Nkarta, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing cell therapies for the treatment of cancer. The company specializes in cellular immunotherapy using chimeric antigen receptors on natural killer cells to target tumor antigens.

Tags: NK cells, biopharmaceutical, cancer treatment, cell therapy, clinical trials, immunotherapy

Symbol: NKTX

Recent Price: $2.32

Industry: Biotechnology

CEO: Mr. Paul J. Hastings

Sector: Healthcare

Employees: 150

Address: 6000 Shoreline Court, South San Francisco, CA 94080

Phone: 415 582 4923

Last updated: 2024-12-31

Predictive Oncology Inc.

Predictive Oncology Inc. logo
Market Cap: Lowest
Employees: Lowest

Personalized Cancer Therapies

Predictive Oncology Inc. is a knowledge-driven company focusing on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States, operating in four segments: Helomics, z PREDICTA, Soluble, and Skyline.

Tags: Artificial Intelligence, Cancer Therapies, Clinical Testing, Disease Models, Drug Discovery, Genomic Profiling, High-Throughput Chromatography

Symbol: POAI

Recent Price: $0.90

Industry: Medical - Instruments & Supplies

CEO: Mr. Raymond F. Vennare

Sector: Healthcare

Employees: 34

Address: 2915 Commers Drive, Eagan, MN 55121

Phone: 651 389 4800

Last updated: 2024-12-31

Personalis, Inc.

Personalis, Inc. logo
Market Cap: Low
Employees: Low

NeXT Platform

Personalis, Inc. is a cancer genomics company that provides sequencing and data analysis services for cancer therapy development and genetic research. Their products include NeXT Platform, NeXT Liquid Biopsy, NeXT Personal, NeXT Dx Test, and ACE platform, serving biopharmaceutical, academic, and government institutions.

Tags: cancer genomics, data analysis, personalized therapy, sequencing, tumor profiling

Symbol: PSNL

Recent Price: $5.97

Industry: Medical - Diagnostics & Research

CEO: Mr. Christopher M. Hall

Sector: Healthcare

Employees: 223

Address: 1330 O’Brien Drive, Menlo Park, CA 94025

Phone: 650 752 1300

Last updated: 2024-12-31

10x Genomics, Inc.

10x Genomics, Inc. logo
Market Cap: High
Employees: Medium

chromium instruments

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems globally. Their products include chromium instruments and single cell solutions for gene expression and immune profiling.

Tags: biological systems, chromium instruments, epigenetics, gene expression, immune profiling, life science, technology

Symbol: TXG

Recent Price: $14.35

Industry: Medical - Healthcare Information Services

CEO: Dr. Serge Saxonov Ph.D.

Sector: Healthcare

Employees: 1259

Address: 6230 Stoneridge Mall Road, Pleasanton, CA 94588-3260

Phone: 925 401 7300

Last updated: 2024-12-31

Xenetic Biosciences, Inc.

Xenetic Biosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

XCART

Xenetic Biosciences, Inc. is a biopharmaceutical company that focuses on advancing XCART, a personalized CAR T platform technology for oncology therapeutics and biologic drug development.

Tags: CAR T, biopharmaceutical, biotechnology, drug delivery, oncology, therapeutics

Symbol: XBIO

Recent Price: $4.05

Industry: Biotechnology

CEO: Mr. James F. Parslow

Sector: Healthcare

Employees: 4

Address: 40 Speen Street, Framingham, MA 01701

Phone: 781 778 7720

Leadership

  • James F. Parslow, Interim Chief Executive Officer and Chief Financial Officer
  • Scott N. Cullison, Business Development
  • Reid P. Bissonnette, Ph.D., Translational Research and Development
  • Cory C. Kauffman, Ph.D., Chief Technology Officer
  • Adam Logal, Chairman
  • Grigory G. Borisenko, Ph.D., Non-Executive Director
  • James Eric Callaway, Ph.D., Non-Executive Director
  • Firdaus Jal Dastoor, FCS, Non-Executive Director
  • Dmitry Genkin, MD, Non-Executive Director
  • Roger Kornberg, Ph.D., Non-Executive Director
  • Moshe Mizrahy, Non-Executive Director
  • Dr. Alexey Vinogradov, Non-Executive Director

Last updated: 2024-12-31

Bionano Genomics, Inc.

Bionano Genomics, Inc. logo
Market Cap: Lowest
Employees: Medium

Saphyr

Bionano Genomics, Inc. provides genome analysis software solutions, including Saphyr for structural variation analysis by optical genome mapping, Nx Clinical for genomic variant interpretation, and laboratory services like First Step Dx PLUS for autism spectrum disorder.

Tags: cytogenetics, genetic variation, genome analysis, molecular genetics, optical genome mapping

Symbol: BNGO

Recent Price: $0.29

Industry: Medical - Diagnostics & Research

CEO: Dr. Robert Erik Holmlin M.B.A., Ph.D.

Sector: Healthcare

Employees: 344

Address: 9540 Towne Centre Drive, San Diego, CA 92121

Phone: 858 888 7600

Last updated: 2024-12-31

Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc. logo
Market Cap: Low
Employees: Lowest

NXP800, NXP900

Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.

Tags: NXP800, NXP900, biopharmaceutical, oncology, precision medicine

Symbol: NVCT

Recent Price: $5.14

Industry: Biotechnology

CEO: Mr. Ron Bentsur M.B.A.

Sector: Healthcare

Employees: 13

Address: 1 Bridge Plaza, Fort Lee, NJ 07024

Phone: 201 614 3150

Last updated: 2024-12-31

Orgenesis Inc.

Orgenesis Inc. logo
Market Cap: Lowest
Employees: Low

Point of Care (POCare) platform

Orgenesis Inc. is a biotech company focusing on cell and gene therapies. It offers a Point of Care (POCare) platform with a pipeline of POCare therapeutics produced in automated systems, targeting autologous therapies near the patient's point of care.

Tags: POCare, autologous therapies, biotech, cell therapy, gene therapy

Symbol: ORGS

Recent Price: $2.11

Industry: Biotechnology

CEO: Ms. Vered Caplan M.Sc.

Sector: Healthcare

Employees: 146

Address: 20271 Goldenrod Lane, Germantown, MD 20876

Phone: 480 659 6404

Last updated: 2024-12-31